Interferon. induced compositional changes in human bone marrow derived mesenchymal stem/stromal cells

被引:27
|
作者
Guan, Qingdong [1 ,2 ]
Ezzati, Peyman [3 ,4 ]
Spicer, Victor [3 ,4 ]
Krokhin, Oleg [3 ,4 ]
Wall, Donna [5 ]
Wilkins, John A. [3 ,4 ]
机构
[1] Univ Manitoba, Dept Pediat & Child Hlth, Manitoba Ctr Adv Cell & Tissue Therapy, Winnipeg, MB, Canada
[2] CancerCare Manitoba, Cellular Therapy Lab, Winnipeg, MB, Canada
[3] Univ Manitoba, Rady Fac Hlth Sci, Dept Internal Med, Manitoba Ctr Prote & Syst Biol,Sect Biomed Prote, 715 McDermot Ave, Winnipeg, MB R3E 3P4, Canada
[4] 799 John Buhler Res Ctr, Hlth Sci Ctr, 715 McDermot Ave, Winnipeg, MB R3E 3P4, Canada
[5] Univ Toronto, Hosp Sick Children, Dept Paediat, Div Haematol Oncol, Toronto, ON, Canada
关键词
Proteomics; Human; 2D LC mass spectrometry; Interferon gamma; Mesenchymal stem/stromal cells ( MSC); Quantitative proteome profiling; Licensing; Membrane; STROMAL CELLS; STEM-CELLS; IFN-GAMMA; INDOLEAMINE 2,3-DIOXYGENASE; PROSTACYCLIN SYNTHASE; TGF-BETA; INDUCTION; IMMUNOSUPPRESSION; SUPPRESSION; ACTIVATION;
D O I
10.1186/s12014-017-9161-1
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Mesenchymal stem/stromal cells ( MSC) display a range of immunoregulatory properties which can be enhanced by the exposure to cytokines such interferon. ( IFN-gamma).However the compositional changes associated with the 'licensing' of these cells have not been clearly defined. The present study was undertaken to provide a detailed comparative proteomic analysis of the compositional changes that occur in human bone marrow derived MSC following 20 h treatment with IFN-gamma. Methods: 2D LC MSMS analysis of control and IFN-gamma treated cells from 5 different healthy donors provided confident identification of more than 8400 proteins. Results: In total 210 proteins were shown to be significantly altered in their expression levels (>=|2SD|) following IFN-gamma treatment. The changes for several of these proteins were confirmed by flow cytometry. STRING analysis determined that approximately 30% of the altered proteins physically interacted in described interferon mediated processes. Comparison of the list of proteins that were identified as changed in the proteomic analysis with data for the same proteins in the Interferome DB indicated that similar to 35% of these proteins have not been reported to be IFN-gamma responsive in a range of cell types. Conclusions: This data provides an in depth analysis of the proteome of basal and IFN-gamma treated human mesenchymal stem cells and it identifies a number of novel proteins that may contribute to the immunoregulatory capacity if IFN-gamma licensed cells.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Effect of High BMI on Human Bone Marrow-Derived Mesenchymal Stromal Cells
    Zong, Qiang
    Bundkirchen, Katrin
    Neunaber, Claudia
    Noack, Sandra
    CELL TRANSPLANTATION, 2024, 33
  • [22] Ruxolitinib Inhibits IFNγ Licensing of Human Bone Marrow Derived Mesenchymal Stromal Cells
    Ryan, Molly Mercedes
    Patel, Mihir
    Hogan, Keenan
    Lipat, Ariel Joy
    Scandolara, Rafaela
    Das, Rahul
    Bruker, Charles
    Galipeau, Jacques
    Chinnadurai, Raghavan
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (05): : 389.e1 - 389.e10
  • [23] Molecular fingerprint of subsets of human bone marrow-derived mesenchymal stromal cells
    Kuci, Selim
    Kuci, Zyrafete
    Schaefer, Richard
    Spohn, Gabriele
    Winter, Stefan
    Klingebiel, Thomas
    Bader, Peter
    BONE MARROW TRANSPLANTATION, 2018, 53 : 683 - 683
  • [24] Human mesenchymal progenitor cells derived from alveolar bone and human bone marrow stromal cells: a comparative study
    Pekovits, Karin
    Kroepfl, Julia Maria
    Stelzer, Ingeborg
    Payer, Michael
    Hutter, Heinz
    Dohr, Gottfried
    HISTOCHEMISTRY AND CELL BIOLOGY, 2013, 140 (06) : 611 - 621
  • [25] Human bone marrow-derived mesenchymal stromal cells increase glioblastoma radioresistance
    Strack, Maren
    Ruehle, Alexander
    Heiland, Dieter Henrik
    Schnell, Oliver
    Grosu, Anca-L.
    Nicolay, Nils Henrik
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 46 - 46
  • [26] Novel Monoclonal Antibodies for the Isolation and Characterization of Bone Marrow Derived Mesenchymal Stem/Stromal Cells
    Sivasubramaniyan, Kavitha
    Harichandan, Abhishek
    Grimm, Sabrina
    Nagy, Andras
    TISSUE ENGINEERING PART A, 2011, 17 (3-4) : 548 - 549
  • [27] Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow
    Song, L
    Tuan, RS
    FASEB JOURNAL, 2004, 18 (06): : 980 - +
  • [28] IMMUNOSUPPRESSIVE ACTIVITY OF HUMAN BONE MARROW-DERIVED MESENCHYMAL STEM CELLS
    Liotta, F.
    Angeli, R.
    Cosmi, L.
    Frosali, F.
    Maggi, L.
    Santarlasci, V
    Krampera, M.
    Maggi, E.
    Romagnani, S.
    Annunziato, F.
    HAEMATOLOGICA, 2008, 93 : S4 - S5
  • [29] Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas
    Nakamizo, A
    Marini, F
    Amano, T
    Khan, A
    Studeny, M
    Gumin, J
    Chen, J
    Hentschel, S
    Vecil, G
    Dembinski, J
    Andreeff, M
    Lang, FF
    CANCER RESEARCH, 2005, 65 (08) : 3307 - 3318
  • [30] EVALUATIONS OF THE EFFECT OF RADIATION ON BONE MARROW DERIVED HUMAN MESENCHYMAL STEM CELLS
    Schmidtke-Schrezenmeier, G.
    Fekete, N.
    Rojewski, M.
    Schrezenmeier, H.
    VOX SANGUINIS, 2010, 99 : 479 - 479